Amgen Inc said it signed aletter of intent for an estimated 75 mln dlr research anddevelopment limited partnership to fund the clinicalinvestigation of certain pharmaceutical products currentlyunder development.    Neither terms of the arrangement nor the products coveredby the partnership were disclosed, but Amgen said the limitedpartnership units will include warrants to purchase Amgencommon stock. Reuter&#3;